What is the latest news on MNLO?

Quantisnow has not tracked any new filings, ratings or press releases for MNLO in the last 30 days. The most recent wire item was published on January 26, 2021.

Where does MNLO stock trade?

Menlo Therapeutics Inc. (MNLO) is listed on NASDAQ.

What sector and industry is MNLO in?

Menlo Therapeutics Inc. operates in the Health Care sector, Major Pharmaceuticals industry.

When did Menlo Therapeutics Inc. go public?

Menlo Therapeutics Inc. (MNLO) completed its IPO in 2018.

What companies are similar to MNLO?

Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare MNLO side-by-side with any of them on Quantisnow.

How can I track MNLO on Quantisnow?

Quantisnow aggregates Menlo Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MNLO to receive live email and push alerts on every new disclosure.

MNLO

NASDAQ

Menlo Therapeutics Inc.

SectorHealth Care IndustryMajor PharmaceuticalsIPO2018

Follow + get alerts

Menlo Therapeutics Inc. (MNLO) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for MNLO in the last 30 days. The most recent was published Jan 26, 2021.

Latest news

1 item

2113dPR
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team
MENLO PARK, Calif.--(BUSINESS WIRE)--Frazier Healthcare Partners announced the planned addition of Albert Cha, M.D., Ph.D. as Managing Partner on the Life Sciences team. He has over 20 years of experience investing in public and private biopharmaceutical and medical device companies. Dr. Cha was previously a Managing Partner at Vivo Capital. He currently serves on the boards of Ascendis Pharma A/S (NASDAQ: ASND) and KalVista Pharmaceuticals (NASDAQ: KALV), and has served on the boards of Aclaris Therapeutics (NASDAQ: ACRS), Biohaven Pharma (NYSE: BHVN), Menlo Therapeutics (NASDAQ: MNLO), Sierra Oncology (NASDAQ: SRRA), Ceptaris Therapeutics (acquired by Actelion), Neomend (acquir

MNLO FAQ

6 questions

What is the latest news on MNLO?
Quantisnow has not tracked any new filings, ratings or press releases for MNLO in the last 30 days. The most recent wire item was published on January 26, 2021.
Where does MNLO stock trade?
Menlo Therapeutics Inc. (MNLO) is listed on NASDAQ.
What sector and industry is MNLO in?
Menlo Therapeutics Inc. operates in the Health Care sector, Major Pharmaceuticals industry.
When did Menlo Therapeutics Inc. go public?
Menlo Therapeutics Inc. (MNLO) completed its IPO in 2018.
What companies are similar to MNLO?
Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare MNLO side-by-side with any of them on Quantisnow.
How can I track MNLO on Quantisnow?
Quantisnow aggregates Menlo Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MNLO to receive live email and push alerts on every new disclosure.